{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T17:37:59Z","timestamp":1781977079166,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10579-1","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T13:07:31Z","timestamp":1738760851000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of invasive and noninvasive pneumococcal diseases on adult populations: risk factors and vaccination status"],"prefix":"10.1186","volume":"25","author":[{"given":"Hasip","family":"Kahraman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u0131nar","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eenay","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcl","family":"Durmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzaffer","family":"Bilgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"\u00c7a\u011flayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"10579_CR1","doi-asserted-by":"crossref","unstructured":"Martinez-Vega R, Jauneikaite E, Thoon KC, Chua HY, Huishi Chua A, Khong WX et al. Risk factor profiles and clinical outcomes for children and adults with pneumococcal infections in Singapore: A need to expand vaccination policy? Melo-Cristino J, editor. PLOS ONE. 2019;14(10):e0220951.","DOI":"10.1371\/journal.pone.0220951"},{"issue":"5","key":"10579_CR2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/MD.0b013e3181f2b824","volume":"89","author":"AM Rueda","year":"2010","unstructured":"Rueda AM, Serpa JA, Matloobi M, Mushtaq M, Musher DM. The Spectrum of Invasive Pneumococcal Disease at an Adult Tertiary Care Hospital in the early 21st century. Med (Baltim). 2010;89(5):331\u20136.","journal-title":"Med (Baltim)"},{"key":"10579_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/1469-0691.12461","volume":"20","author":"JJC Drijkoningen","year":"2014","unstructured":"Drijkoningen JJC, Rohde GGU. Pneumococcal infection in adults: burden of disease. Clin Microbiol Infect. 2014;20:45\u201351.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10579_CR4","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1513\/AnnalsATS.201511-778FR","volume":"13","author":"AC Berical","year":"2016","unstructured":"Berical AC, Harris D, Dela Cruz CS, Possick JD. Pneumococcal vaccination strategies. An update and perspective. Ann Am Thorac Soc. 2016;13(6):933\u201344.","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10579_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.vhri.2013.07.003","volume":"2","author":"N Maimaiti","year":"2013","unstructured":"Maimaiti N, Ahmed Z, Md Isa Z, Ghazi HF, Aljunid S. Clinical Burden of Invasive Pneumococcal Disease in selected developing countries. Value Health Reg Issues. 2013;2(2):259\u201363.","journal-title":"Value Health Reg Issues"},{"key":"10579_CR6","doi-asserted-by":"crossref","unstructured":"Kobayashi M. Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines Among Adults Aged\u2009\u2265\u200950 Years: Recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2024. MMWR Morb Mortal Wkly Rep [Internet]. 2025 [cited 2025 Jan 21];74. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/74\/wr\/mm7401a1.htm","DOI":"10.15585\/mmwr.mm7401a1"},{"key":"10579_CR7","unstructured":"Eri\u015fkin Ba\u011f\u0131\u015f\u0131klama. Rehberi 2024 - EKMUD [Internet]. [cited 2024 Apr 24]. Available from: https:\/\/www.ekmud.org.tr\/haber\/1151-eriskin-bagisiklama-rehberi-2024"},{"key":"10579_CR8","doi-asserted-by":"crossref","unstructured":"Kobayashi M, United States. Pneumococcal Vaccine for Adults Aged\u2009\u2265\u200919 Years: Recommendations of the Advisory Committee on Immunization Practices, 2023. MMWR Recomm Rep [Internet]. 2023 [cited 2024 Jan 12];72. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/72\/rr\/rr7203a1.htm","DOI":"10.15585\/mmwr.rr7203a1"},{"issue":"3","key":"10579_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/14760584.2021.1898377","volume":"20","author":"A Deb","year":"2021","unstructured":"Deb A, Mohanty S, Ou W, Rajagopalan S, Johnson KD. Pneumococcal vaccination coverage among adults aged 19 to 64 years with immuno-compromising conditions, cerebrospinal fluid (CSF) leaks, or cochlear implants in the US. Expert Rev Vaccines. 2021;20(3):331\u201345.","journal-title":"Expert Rev Vaccines"},{"key":"10579_CR10","doi-asserted-by":"publisher","first-page":"759602","DOI":"10.3389\/fpubh.2021.759602","volume":"9","author":"KD Zens","year":"2022","unstructured":"Zens KD, Baroutsou V, Fehr JS, Lang P. Pneumococcal Vaccination Coverage and Uptake among adults in Switzerland: a Nationwide Cross-sectional Study of Vaccination records. Front Public Health. 2022;9:759602.","journal-title":"Front Public Health"},{"key":"10579_CR11","doi-asserted-by":"crossref","unstructured":"Rosamilia F, Noberasco G, Olobardi D, Orsi A, Icardi G, Lantieri F et al. Flu and Pneumococcal Vaccine Coverage in Scleroderma patients still need to be prompted: a systematic review. Vaccines. 2021;9(11).","DOI":"10.3390\/vaccines9111330"},{"issue":"12","key":"10579_CR12","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","volume":"372","author":"MJM Bonten","year":"2015","unstructured":"Bonten MJM, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Gault S, et al. Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in adults. N Engl J Med. 2015;372(12):1114\u201325.","journal-title":"N Engl J Med"},{"issue":"5","key":"10579_CR13","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1093\/infdis\/jiab474","volume":"225","author":"JY Heo","year":"2022","unstructured":"Heo JY, Seo YB, Choi WS, Kim EJ, Jeong HW, Lee J, et al. Effectiveness of Pneumococcal Vaccination against Pneumococcal Pneumonia Hospitalization in older adults: a prospective, test-negative study. J Infect Dis. 2022;225(5):836\u201345.","journal-title":"J Infect Dis"},{"issue":"2","key":"10579_CR14","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1086\/600045","volume":"49","author":"AGSC Jansen","year":"2009","unstructured":"Jansen AGSC, Rodenburg GD, Van Der Ende A, van Alphen L, Veenhoven RH, Spanjaard L, et al. Invasive pneumococcal disease among adults: associations among serotypes, Disease characteristics, and Outcome. Clin Infect Dis. 2009;49(2):e23\u20139.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10579_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/antibiotics12010172","volume":"12","author":"R Gil-Prieto","year":"2023","unstructured":"Gil-Prieto R, Allouch N, Jimeno I, Hern\u00e1ndez-Barrera V, Arguedas-Sanz R, Gil-de-Miguel \u00c1. Burden of hospitalizations related to pneumococcal infection in Spain (2016\u20132020). Antibiotics. 2023;12(1):172.","journal-title":"Antibiotics"},{"issue":"2","key":"10579_CR16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.rmed.2008.08.006","volume":"103","author":"A Vila-Corcoles","year":"2009","unstructured":"Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Raga-Luria X, Gomez-Bertomeu F. Epidemiology of community-acquired pneumonia in older adults: a population-based study. Respir Med. 2009;103(2):309\u201316.","journal-title":"Respir Med"},{"issue":"3","key":"10579_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1086\/431521","volume":"192","author":"MH Kyaw","year":"2005","unstructured":"Kyaw MH, Rose CE Jr., Fry AM, Singleton JA, Moore Z, Zell ER, et al. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis. 2005;192(3):377\u201386.","journal-title":"J Infect Dis"},{"key":"10579_CR18","doi-asserted-by":"crossref","unstructured":"Kobayashi M. Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2022. MMWR Morb Mortal Wkly Rep [Internet]. 2022 [cited 2023 Nov 29];71. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7104a1.htm","DOI":"10.15585\/mmwr.mm7104a1"},{"issue":"36","key":"10579_CR19","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1016\/j.vaccine.2012.05.076","volume":"30","author":"D Weycker","year":"2012","unstructured":"Weycker D, Sato R, Strutton D, Edelsberg J, Atwood M, Jackson LA. Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged \u2265 50 years. Vaccine. 2012;30(36):5437\u201344.","journal-title":"Vaccine"},{"issue":"5","key":"10579_CR20","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s15010-018-1169-6","volume":"46","author":"M Garrouste-Orgeas","year":"2018","unstructured":"Garrouste-Orgeas M, Azoulay E, Ruckly S, Schwebel C, de Montmollin E, Bedos JP, et al. Diabetes was the only comorbid condition associated with mortality of invasive pneumococcal infection in ICU patients: a multicenter observational study from the Outcomerea research group. Infection. 2018;46(5):669\u201377.","journal-title":"Infection"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10579-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10579-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10579-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T13:07:35Z","timestamp":1738760855000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10579-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10579"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10579-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"4 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki and approved by the Eski\u015fehir Osmangazi University Non-Interventional Clinical Research Ethics Committee, with reference number 2022\u2009\u2212\u2009208. Since this study did not involve direct interaction with human participants requiring individual consent, the need for informed consent to participate was waived by the ethics committee in accordance with national regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"172"}}